Full Text View
Tabular View
No Study Results Posted
Related Studies
Buprenorphine Detox With Two Types of Treatment. BBD I - 10
This study has been completed.
Study NCT00000228   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 20, 1999   Last Updated: August 16, 2005   History of Changes

September 20, 1999
August 16, 2005
August 1994
 
  • Drug use
  • Retention
  • Weeks abstinent
  • Weeks continuous abstinence
  • Overall treatment outcome
Same as current
Complete list of historical versions of study NCT00000228 on ClinicalTrials.gov Archive Site
 
 
 
Buprenorphine Detox With Two Types of Treatment. BBD I - 10
Buprenorphine Detox With Two Types of Treatment. BBD I

The purpose of this study is to compare overall treatment outcome between behavioral versus standard treatment types.

 
Phase II
Interventional
Treatment
Opioid-Related Disorders
Drug: Buprenorphine
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
0
 
 

Please contact site for information.

Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00000228
 
NIDA-06969-10, R01-06969-10
National Institute on Drug Abuse (NIDA)
University of Vermont
Principal Investigator: Warren Bickel, Ph.D. University of Vermont
National Institute on Drug Abuse (NIDA)
July 1996

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP